Clinical Trials Directory

Trials / Conditions / Regorafenib

Regorafenib

8 registered clinical trials studyying Regorafenib — 2 currently recruiting.

StatusTrialSponsorPhase
SuspendedRegorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Can
NCT07071961
M.D. Anderson Cancer CenterPhase 2
RecruitingEfficacy and Safety Study of DC-CIK Cell Therapy Combined With Epaloliposide, Vortexil, and Regorafenib as Thi
NCT07343791
JIANG LONGWEIEARLY_Phase 1
UnknownTAS-102 in Combination With Regorafenib or Fruquintinib for Third-line and Above Advanced Colorectal Cancer
NCT05993702
China Medical University, China—
RecruitingRegorafenib Combined With Irinotecan Drug-Eluting Beads for Colorectal Cancer Liver Metastases
NCT05794971
Sun Yat-sen UniversityPhase 3
UnknownRegorafenib Alone or in Combined With Transcatheter Arterial ChEmoembolization in Treatment of Advanced Hepato
NCT05811481
WenBo Guo—
UnknownRegorafenib Plus Raltitrexed as Third-line Treatment in Advanced Colorectal Cancer Patients
NCT05426811
China Medical University, ChinaPhase 1 / Phase 2
UnknownRegorafenib Combined With PD-1 Inhibitor Therapy for Second-line Treatment of Hepatocellular Carcinoma
NCT05048017
Peking Union Medical College HospitalPhase 2
UnknowncTACE or DEB-TACE+HAIC Combined With Regorafenib ± Anti-PD1 Antibody for uHCC
NCT05025592
Peking University Cancer Hospital & Institute—